DARZALEX 1.800 MG SOLUCION INYECTABLE
DARZALEX 1.800 MG SOLUCION INYECTABLE
Pending
Register Number
1161101004IP1
Prescription Type
Uso Hospitalario
Authorization Date
Jun 17, 2025
Dosage Form
SOLUCIÓN INYECTABLE
Route: VÍA SUBCUTÁNEA
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1161101004IP1
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✗
Commercialized
No
CIMA AEMPS Classification
INGREDIENTS (1)
DARATUMUMABActive
Quantity: 1800 mg
Name: DARATUMUMAB
ATC CLASSIFICATION (3)
L01F
L01FC
L01FC01